-
Mashup Score: 0
1 in 5 persons participating in the study lost detectable antibody response, and over 70% lost protective levels of antibody within 6 months
Source: financialpostCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3
Life insurance can be a lifelong financial friend whether it’s for estate planning, investing or as tax-free deposits into your account at retirement
Source: financialpostCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Plant-based meals never looked better thanks to Boosh - 3 year(s) ago
Flexitarians — people who follow a semi-vegetarian diet — make up a large and rapidly growing segment of the food-buying market.
Source: financialpostCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 8
The highest-selling virtual plot went for more than $1 million
Source: financialpostCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5Restaurants' Fragile Recovery Is Fizzling in the U.S. - 3 year(s) ago
(Bloomberg) — After a brief glimpse of normalcy this summer, the fragile recovery in the U.S. restaurant industry is sputtering.
Source: financialpostCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5
WASHINGTON — The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle…
Source: financialpostCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 77Boondoggle: How Ontario's pursuit of renewable energy broke the province's electricity system - 3 year(s) ago
The Ontario green electricity regime is a monumental failure. The costs to consumers are prohibitive and damaging the economy
Source: financialpostCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
ZURICH — Novartis said on Friday it received approval from the European Commission for Leqvio, also known as inclisiran, a drug to lower cholesterol that the…
Source: financialpostCategories: Cardiologists, Latest HeadlinesTweet
Study of SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis https://t.co/gfv84qCduF